Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | TSHR | P16473 | 3/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.54 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.54 |
| ▸ | CASP1 | P29466 | 1/20 | 0.54 |
| ▸ | CASP7 | P55210 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1684564 | 0.81 | TSHR (0.67) | POLBSMN1; SMN2TSHRPKMATM | |
| SCHEMBL16026507 | 0.80 | ATM (0.58) | POLBSMN1; SMN2TSHRPKMATM | |
| SCHEMBL54427 | 0.79 | USP2 (0.66) | POLBSMN1; SMN2TSHRATMCASP1 | |
| SCHEMBL3407424 | 0.79 | USP2 (0.66) | POLBSMN1; SMN2TSHRATMCASP1 | |
| SCHEMBL3405913 | 0.79 | USP2 (0.66) | POLBSMN1; SMN2TSHRATMCASP1 | |
| SCHEMBL3406366 | 0.79 | USP2 (0.66) | POLBSMN1; SMN2TSHRATMCASP1 | |
| SCHEMBL15014129 | 0.78 | PKM (0.89) | POLBSMN1; SMN2TSHRPKMHTT | |
| SCHEMBL3936569 | 0.77 | POLB (1.00) | POLBSMN1; SMN2TSHRPKMATM | |
| SCHEMBL28086690 | 0.77 | CASP7 (0.53) | POLBSMN1; SMN2TSHRATMCASP1 | |
| SCHEMBL20302795 | 0.76 | KDM4E (0.69) | POLBSMN1; SMN2TSHRATMCASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1377536-A4 | SELF-REDUCING ANTHRAQUINONE COMPOUNDS | COMMW SCIENT AND RES ORGANISAT (AU) | 2007-02-28 | — | — | EP | claimed |
| US-20040175314-A1 | Self-reducing anthraquinone compounds | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORAGNISATION (AU) | 2004-09-09 | — | — | US | claimed |
| EP-1377536-A1 | SELF-REDUCING ANTHRAQUINONE COMPOUNDS | Commonwealth Scientific and Research Organisation (AU) | 2004-01-07 | — | — | EP | claimed |
| WO-2002076916-A1 | SELF-REDUCING ANTHRAQUINONE COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2002-10-03 | — | — | WO | claimed |
| EP-1377536-A4 | SELF-REDUCING ANTHRAQUINONE COMPOUNDS | COMMW SCIENT AND RES ORGANISAT (AU) | 2007-02-28 | — | — | EP | disclosed |
| US-20040175314-A1 | Self-reducing anthraquinone compounds | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORAGNISATION (AU) | 2004-09-09 | — | — | US | disclosed |
| EP-1377536-A1 | SELF-REDUCING ANTHRAQUINONE COMPOUNDS | Commonwealth Scientific and Research Organisation (AU) | 2004-01-07 | — | — | EP | disclosed |
| WO-2002076916-A1 | SELF-REDUCING ANTHRAQUINONE COMPOUNDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2002-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040175314-A1 | Self-reducing anthraquinone compounds | XDH, SQOR, NQO1 | POLB 744/4885SMN1; SMN2 3801/4885TSHR 2201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.